drugset / Trial / NCT00650624
A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the therapeutic dose range of valdecoxib by comparing the efficacy of three dosing regimens (5 mg, 10 mg and 20 mg once daily) with placebo for relief of the signs and symptoms of osteoarthritis of the knee. To assess safety and tolerability of multiple doses of valdecoxib in patients with osteoarthritis of the knee.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | valdecoxib | Small molecule | 5 mg | Oral |
| Comparator | valdecoxib | Small molecule | 10 mg | Oral |
| Comparator | valdecoxib | Small molecule | 20 mg | Oral |